Clinical trial • Phase III • Other
glyceryl trinitrate for Genitourinary Syndrome of Menopause
Phase III trial of glyceryl trinitrate for Genitourinary Syndrome of Menopause. 32 participants.
Overview
- Trial Therapeutic Area
- Other
- Trial Disease
- Genitourinary Syndrome of Menopause
- Trial Stage
- Phase III
- Drug Modality
- Small molecule
Key dates
- Initial CTIS Submission Date
- 29-01-2025
- First CTIS Authorization Date
- 05-02-2025
Trial design
Phase III trial across 1 site in Austria.
- Target Sample Size
- 32
Recruitment
- Planned Sample Size
- 32
- Recruitment Window Months
- 34
Geography
- Total Number Of Sites
- 1
- Total Number Of Participants
- 32
Austria
- Earliest CTIS Part Ii Submission Date
- 21-01-2025
- Latest Decision Or Authorization Date
- 05-02-2025
- Processing Time Days
- 15
- Number Of Sites
- 1
- Number Of Participants
- 32
Sites
- Site Name
- Medical University Of Vienna
- Department Name
- Department of Clinical Pharmacology
- Contact Person Name
- Michaela Bayerle-Eder
- Contact Person Email
- michaela.bayerle-eder@meduniwien.ac.at
- Number Of Participants
- 32
Sponsor
Primary sponsor
- Full Name
- Medical University Of Vienna
- Organisation Type
- Educational Institution
- Country Of Registered Address
- Austria
Investigational products
- Investigational Product Name
- NitroVAG (topical glyceryl trinitrate)
- Active Substance
- glyceryl trinitrate
- Modality
- Small molecule
- Routes Of Administration
- topical (cream)
- Route
- topical
Related trials
Other published trials that may interest you.